1. Buchdunger E, Zimmerman J, Mett H, Meyer T, Muller M, Druker B et al. (1996). Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res 56: 100–104.
2. Bunn P, Franklin W . (2002). Epidermal growth factor receptor expression, signal pathway, and inhibitors in non-small cell lung cancer. Semin Oncol 29 (5 Suppl 14): 38–44.
3. Dowell J, Minna J . (2005). Chasing mutations in the epidermal growth factor in lung cancer. N Engl J Med 352: 830–832.
4. Girard L, Zochbauer-Muller S, Virmani A, Gazdar A, Minna J . (2000). Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res 60: 4894–4906.
5. Hantschel O, Nagar B, Guettler S, Kretzschmar J, Dorey K, Kuryian J et al. (2003). A myristoyl/phosphotyrosine switch regulates c-Abl. Cell 112: 845–857.